236 related articles for article (PubMed ID: 1606517)
1. Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes.
Schwartz SA
Clin Rev Allergy; 1992; 10(1-2):1-12. PubMed ID: 1606517
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immune globulin in primary immunodeficiency.
Haeney M
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):11-5. PubMed ID: 8033427
[TBL] [Abstract][Full Text] [Related]
3. [Immunoglobulins--merely expensive or also useful?].
Paar WD
Ther Umsch; 1995 Oct; 52(10):639-44. PubMed ID: 7482374
[TBL] [Abstract][Full Text] [Related]
4. Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin.
Esmaeilzadeh H; Askarisarvestani A; Hosseini N; Samimi S; Shafiei A; Mahdaviani SA; Eslami N; Chavoshzadeh Z; Fallahi M; Khakbazanfard N; Shabestari MS; Aleyasin S; Nabavizadeh SH; Cheraghi T; Kalantari A; Ahmadiafshar A; Safari M; Eslamian MH; Molatefi R; Shirkani A; Heidarzadeh Arani M; Tavakol M; Bemanian MH; Arshi S; Nabavi M; Shokri S; Shahhosseini B; Mortazavi N; Nakhaei P; Nazari F; Fallahpour M; Ahanchian H; Moazzen N; Khoshkhui M; Motlagh AV; Aghamohammadi A; Abolhassani H; Yazdani R; Rezaei N
Clin Immunol; 2021 Sep; 230():108826. PubMed ID: 34418548
[TBL] [Abstract][Full Text] [Related]
5. [Immunoglobulins and immune deficiency: methods of administration].
Suarez F
Rev Med Interne; 2005 Oct; 26 Spec No 1():25-8. PubMed ID: 16475260
[No Abstract] [Full Text] [Related]
6. Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases.
Dashti-Khavidaki S; Aghamohammadi A; Farshadi F; Movahedi M; Parvaneh N; Pouladi N; Moazzami K; Cheraghi T; Mahdaviani SA; Saghafi S; Heydari G; Abdollahzade S; Rezaei N
J Investig Allergol Clin Immunol; 2009; 19(2):139-45. PubMed ID: 19476018
[TBL] [Abstract][Full Text] [Related]
7. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency.
Aghamohammadi A; Farhoudi A; Nikzad M; Moin M; Pourpak Z; Rezaei N; Gharagozlou M; Movahedi M; Atarod L; Afshar AA; Bazargan N; Hosseinpoor AR
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):60-4. PubMed ID: 14756466
[TBL] [Abstract][Full Text] [Related]
8. [Personal experience with replacement therapy with intravenous gamma globulin].
Litzman J; Lokaj J; Stikarovská D; Mayer J; Thon V; Eibl MM
Vnitr Lek; 1995 Nov; 41(11):759-63. PubMed ID: 8553594
[TBL] [Abstract][Full Text] [Related]
9. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.
McCormack PL
BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous Immunoglobulin Therapy for Hypogammaglobulinemia Secondary to Malignancy or Related Drug Therapy.
Windegger TM; Lambooy CA; Hollis L; Morwood K; Weston H; Fung YL
Transfus Med Rev; 2017 Jan; 31(1):45-50. PubMed ID: 27450021
[TBL] [Abstract][Full Text] [Related]
11. Human intravenous immunoglobulin in primary and secondary antibody deficiencies.
Stiehm ER
Pediatr Infect Dis J; 1997 Jul; 16(7):696-707. PubMed ID: 9239774
[TBL] [Abstract][Full Text] [Related]
12. Anaphylaxis to IVIG.
Williams SJ; Gupta S
Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):11-19. PubMed ID: 27412077
[TBL] [Abstract][Full Text] [Related]
13. Reversible Hypogammaglobulinemia in 2 Pediatric Patients With Primary Immunodeficiency.
Pasic S
J Investig Allergol Clin Immunol; 2017; 27(5):320-321. PubMed ID: 29057740
[No Abstract] [Full Text] [Related]
14. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.
Orange JS; Grossman WJ; Navickis RJ; Wilkes MM
Clin Immunol; 2010 Oct; 137(1):21-30. PubMed ID: 20675197
[TBL] [Abstract][Full Text] [Related]
15. A new intravenous immunoglobulin (BIVIGAM®) for primary humoral immunodeficiency.
Wasserman RL
Expert Rev Clin Immunol; 2014 Mar; 10(3):325-37. PubMed ID: 24527947
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of immunoglobulin replacement therapy in patients with secondary antibody deficiency.
Patel V; Cowan J
Expert Rev Clin Immunol; 2020 Jul; 16(7):711-716. PubMed ID: 32588670
[TBL] [Abstract][Full Text] [Related]
17. Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions.
Bichuetti-Silva DC; Furlan FP; Nobre FA; Pereira CT; Gonçalves TR; Gouveia-Pereira M; Rota R; Tavares L; Mazzucchelli JT; Costa-Carvalho BT
Int Immunopharmacol; 2014 Dec; 23(2):442-6. PubMed ID: 25257732
[TBL] [Abstract][Full Text] [Related]
18. [Substitution therapy for deficiencies in antibody production by immunoglobulins].
Strengers PF
Arch Pediatr; 1999; 6 Suppl 2():423s-424s. PubMed ID: 10370557
[No Abstract] [Full Text] [Related]
19. Intravenous immunoglobulins in infectious diseases: where do we stand?
Mouthon L; Lortholary O
Clin Microbiol Infect; 2003 May; 9(5):333-8. PubMed ID: 12848745
[TBL] [Abstract][Full Text] [Related]
20. Intravenous Immunoglobulin in the Treatment of Primary Immunodeficiency Diseases.
De Ranieri D; Fenny NS
Pediatr Ann; 2017 Jan; 46(1):e8-e12. PubMed ID: 28079912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]